BSE - Delayed Quote INR

Lotus Eye Hospital and Institute Limited (LOTUSEYE.BO)

Compare
70.68
+0.33
+(0.47%)
At close: 3:47:45 PM GMT+5:30
Loading Chart for LOTUSEYE.BO
DELL
  • Previous Close 70.35
  • Open 70.35
  • Bid 69.91 x --
  • Ask --
  • Day's Range 69.00 - 70.72
  • 52 Week Range 44.10 - 91.00
  • Volume 1,660
  • Avg. Volume 3,533
  • Market Cap (intraday) 1.47B
  • Beta (5Y Monthly) 0.38
  • PE Ratio (TTM) 103.94
  • EPS (TTM) 0.68
  • Earnings Date Feb 12, 2025 - Feb 17, 2025
  • Forward Dividend & Yield 0.50 (0.67%)
  • Ex-Dividend Date Sep 18, 2023
  • 1y Target Est --

Lotus Eye Hospital and Institute Limited, a specialty eye care hospital, provides eye care and related services in India. The company offers ReLEx SMILE lasik, touch free laser, lasik eye surgery, epilasik, intralase, supracor, robotic femto laser cataract surgery, phacoemulsification, paediatric eye care and squint surgery, and micro incision cataract surgery treatments. It also provides epizyoptix, special kertometer, and synaptophore; SICS, Phaco, MICS, LRCS, SFLOL, and SF IOL cataract surgery; corneal patchgraft, scleral repair, scrapping + AMG, suture, tatooing, tear suturing, and drop removal; pertygium, C3R, penetrating keratoplasty, TPK and DALK, and DASE; membrane peeling and endolaser; ERM removal, silicon oil and removal, vitrectomy lavage, FGE and C3F8, LPFC and CYCLO CRYO, and scleral buckling and belt buckle; ivta, avastin, razumab, ozurdex, zybev, eyelea, lucentis, and accentrix injections; trabeculectomy; and enucleation, evisceration, DCR and DCT, PTOSIS, and lateral tarsorrhaphy services. In addition, the company offers services in the areas of refractive, cataract, cornea infections, ocular prosthesis, orbit and oculoplasty, glaucoma, keratoconus, computer vision syndrome, neuro ophthalmology, retinal disease/diabetic eye care, uvea and ocular inflammation, zyoptix ultimate, and binocular vision. Further, it operates an eye bank, optical showroom, pharmacy, and research trust; and offers a Bachelor of Science degree in optometry, various optical fellowship courses, and a DNB program. The company was formerly known as Lotus Eye Care Hospital Limited and changed its name to Lotus Eye Hospital and Institute Limited in April 2013. Lotus Eye Hospital and Institute Limited was founded in 1989 and is based in Coimbatore, India.

www.lotuseye.org

336

Full Time Employees

March 31

Fiscal Year Ends

Recent News: LOTUSEYE.BO

View More

Performance Overview: LOTUSEYE.BO

Trailing total returns as of 1/17/2025, which may include dividends or other distributions. Benchmark is

.

YTD Return

LOTUSEYE.BO
5.68%
S&P BSE SENSEX
2.08%

1-Year Return

LOTUSEYE.BO
23.98%
S&P BSE SENSEX
4.77%

3-Year Return

LOTUSEYE.BO
36.93%
S&P BSE SENSEX
25.15%

5-Year Return

LOTUSEYE.BO
184.08%
S&P BSE SENSEX
82.72%

Compare To: LOTUSEYE.BO

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: LOTUSEYE.BO

View More

Valuation Measures

Annual
As of 1/16/2025
  • Market Cap

    1.46B

  • Enterprise Value

    1.45B

  • Trailing P/E

    103.46

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    3.05

  • Price/Book (mrq)

    2.43

  • Enterprise Value/Revenue

    3.03

  • Enterprise Value/EBITDA

    22.41

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    4.44%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    485.33M

  • Net Income Avi to Common (ttm)

    21.54M

  • Diluted EPS (ttm)

    0.68

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    69.3M

  • Total Debt/Equity (mrq)

    1.87%

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: LOTUSEYE.BO

View More

Company Insights: LOTUSEYE.BO

Research Reports: LOTUSEYE.BO

View More

People Also Watch